As any good contrarian investor knows, the time to buy is when there’s blood on the streets. The roads of America may not yet be sanguinary, but virtually every stock on the list below has been bleeding for the past two or so months. That means they’re a lot cheaper than they once were, and in many instances undeservedly so. We took advantage of the recent Morningstar Investment Conference in Chicago to buttonhole a baker’s dozen of managers and ask them to name the single stock that investors had to own. Their answers are below. Share prices and related data are as of the July 6 close. (more)
No comments:
Post a Comment